Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents and receptor modulators. Its structure supports binding to biological targets involved in neurological disorders, making it valuable in medicinal chemistry for creating potent and selective drug candidates. The presence of the trifluoromethyl group enhances metabolic stability and lipophilicity, improving blood-brain barrier penetration. Commonly employed in research settings for optimizing lead compounds in drug discovery programs.